Although existing transcriptome studies lack the necessary depth and specificity required for a comprehensive characterization of ROS1-driven NSCLC, we hypothesized that reanalysis based on combined data can yield a more representative characterization of this tumor type (39–41). Here, ROS1 is linked to neoplasm.